A homeopathic approach to treat patients with advanced gallbladder, periampullary, and liver carcinomas: a report of 3 cases

The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
Aradeep Chatterjee, Jaydip Biswas

Abstract

The authors present 3 cases of various pathologically confirmed malignancies (one gallbladder, one periampullary, and one liver). These patients underwent Psorinum therapy as the primary cancer treatment. Psorinum therapy is a homeopathic approach to treat patients with cancer. According to the American Joint Committee on Cancer tumor, nodes, metastasis system, all 3 patients were diagnosed at Stage IV. Their Karnofsky performance status was between 20% and 50% and their Eastern Cooperative Oncology Group score status was between 3 and 4. In these cases, conventional cancer treatments could not be initiated due to the advanced stage of their disease, poor general health performance status, and their financial constraints. In these patients, Psorinum-6x was administered orally at a dose of 0.02 mL/kg body weight/day on an empty stomach for a complete course duration of 2 years, along with allopathic and homeopathic supportive treatment. According to the Response Evaluation Criteria in Solid Tumors criteria, complete tumor response occurred in 1 case and partial tumor response occurred in the other 2 cases. All 3 patients remained alive and maintained a stable quality of life for at least 2 years. The patients reported no adverse...Continue Reading

References

Jul 27, 2002·The Lancet Oncology·Sanjoy Kumar Pal
Jul 31, 2002·The Lancet Oncology·Clare Sansom, Geoffrey Mutuma
Dec 10, 2003·Seminars in Oncology·Maria Theodoulou, Andrew D Seidman
Jan 23, 2004·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Sanjoy Kumar Pal, Balraj Mittal
May 25, 2005·Integrative Cancer Therapies·Judith S JacobsonAlfred I Neugut
Dec 13, 2005·Nature Clinical Practice. Oncology·Lisa Hutchinson, Vincent T DeVita
Feb 8, 2006·Nature Clinical Practice. Oncology·Stuart M Lichtman
Nov 23, 2006·Hematology/oncology Clinics of North America·David Schiff, Patrick Wen
Apr 22, 2008·Investigational New Drugs·Johan VansteenkistePatrick Schöffski
May 10, 2008·American Journal of Surgery·Stavros GourgiotisNikolaos S Salemis
Sep 26, 2008·Integrative Cancer Therapies·Hwa Seung YooMichael S Hong
May 13, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn D SeibBrent T Shoji
Aug 5, 2009·World Journal of Surgery·Gaurav AgarwalMarko Margaritoni
Jan 16, 2010·Expert Opinion on Investigational Drugs·Piotr Jan Wysocki
Feb 18, 2010·Surgical Oncology Clinics of North America·Philip A Philip

❮ Previous
Next ❯

Citations

Dec 4, 2012·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Sanjoy Kumar Pal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Related Papers

Evidence-based Complementary and Alternative Medicine : ECAM
Aradeep ChatterjeeSyamsundar Mandal
The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
Sanjoy Kumar Pal
The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
Sanjoy Kumar Pal, Balraj Mittal
British Journal of Haematology
Stella J BowcockMadan M Ryali
© 2022 Meta ULC. All rights reserved